Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Incidence of Non-Hodgkin's Lymphoma by County, New Mexico, 2017-2021

Indicator Report Data View Options

Incidence of Non-Hodgkin's Lymphoma by County, New Mexico, 2017-2021

  • #This count or rate is statistically unstable (RSE >0.30), and may fluctuate widely across time periods due to random variation (chance). Please use caution in interpreting this value, or combine years, areas, or age groups to increase the population size.
  • ##The estimate has a relative standard error greater than 50% and does not meet standards for reliability. A count or rate such as this should not be used to inform decisions. Try combining years, areas, or age groups to increase the population size.

Why Is This Important?

Non-Hodgkin's lymphoma (NHL) refers to cancers of the lymphatic system. Each year, NHL accounts for over 4% of all new cancer cases and over 3% of all cancer deaths in the U.S. This equates to approximately 80,470 cases and 20,250 deaths. The five-year survival rate is 74%. The causes of NHL are unknown, but studies have shown an association with certain chemicals that may impair the immune system, as well as certain types of viruses. The common mechanism for these factors appears to be immunosuppression.

Definition

Non-Hodgkin's lymphoma (NHL) incidence refers to the number of persons newly diagnosed with NHL within a specified time period. Measures include 1) age-adjusted NHL incidence rates (adjusted by the direct method to the 2000 US standard population); and 2) age-adjusted incidence rates by race/ethnicity. All rates are expressed per 100,000 persons.

Data Notes

  • Rates have been age-adjusted using the direct method and the 2000 U.S. standard population.
  • Rates have been age-adjusted using the direct method and the 2000 U.S. standard population.

Data Sources

How the Measure is Calculated

  • Numerator:

    The number of NHL cases newly diagnosed in New Mexico residents within a specified time period. The data are based on the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program incidence site recode for NHL: 33041-33042. http://seer.cancer.gov/siterecode/
  • Denominator:

    The estimated population of New Mexico residents during a specified time period.

Data Issues

  • New Mexico Population Estimates

    All population estimates apply to July 1 of the selected year. These estimates are considered the most accurate estimates for the state of New Mexico and should match those found on the University of New Mexico Geospatial and Population Studies website. Estimates include decimal fractions. Census tract population estimates were summed to produce County and Small Area population estimates. Population estimate totals may vary due to rounding. Population estimates for previous years are occasionally revised as new information becomes available. When publishing trend data, always be sure that your rates for earlier years match current rates on NM-IBIS that have been calculated with the most up-to-date population estimates.

  • New Mexico Tumor Registry

    In agreement with the New Mexico Tumor Registry, to ensure confidentiality the count of cancer cases is suppressed for any given county if the count is between one and four and the population is less than 1,000. NOTE: The COVID-19 pandemic disrupted health services, leading to delays and reductions in cancer screening, diagnosis, and reporting to some central cancer registries. This may have contributed to an observed decline in 2020 incidence for most cancer sites.

Health Topic Pages Related to: Cancer Incidence - Non-Hodgkin's Lymphoma

Indicator Data Last Updated On 01/14/2024, Published on 07/31/2024
Environmental Health Epidemiology Bureau, Environmental Public Health Tracking Program, Epidemiology and Response Division, New Mexico Department of Health, 1190 S. Saint Francis Drive, Suite 1300, Santa Fe, NM 87505, Srikanth Paladugu, Bureau Chief, Srikanth.Paladugu@doh.nm.gov, or Chelsea Langer, Environmental Epidemiologist Supervisor, Chelsea.Langer@doh.nm.gov